1992
DOI: 10.1016/0098-2997(92)90006-l
|View full text |Cite
|
Sign up to set email alerts
|

Carnosine: Its properties, functions and potential therapeutic applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
185
0
2

Year Published

1998
1998
2013
2013

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 282 publications
(192 citation statements)
references
References 94 publications
3
185
0
2
Order By: Relevance
“…However, as pointed out by Quinn et al (1992), in the same year many claims of therapeutic effects were not substantiated by rigorous experimental examination nor have they been subjected to double blind clinical trials. During the last 20 years, little has changed and we agree when Quinn et al (1992) state that ''where the evidence is more convincing there is encouragement to undertake further studies to test such claims''. We think that the only way to find out whether carnosine will be a useful drug is to test it in rigorous clinical studies with sufficiently large patient numbers.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, as pointed out by Quinn et al (1992), in the same year many claims of therapeutic effects were not substantiated by rigorous experimental examination nor have they been subjected to double blind clinical trials. During the last 20 years, little has changed and we agree when Quinn et al (1992) state that ''where the evidence is more convincing there is encouragement to undertake further studies to test such claims''. We think that the only way to find out whether carnosine will be a useful drug is to test it in rigorous clinical studies with sufficiently large patient numbers.…”
Section: Discussionmentioning
confidence: 99%
“…In general, the positive effects of carnosine are manifold; there is a substantial literature on its protective effects (Quinn et al 1992;Hipkiss 2009b), including astroglial cell protection by NO-trapping (Nicoletti et al 2007) and protection against hypoxia-ischaemia brain damage (Zhang et al 2011). It has been reported that carnosine reduces the development of inflammation and tissue injury associated with spinal cord trauma (Di Paola et al 2011); it also protects lung tissue against bleomycin-induced injury (Cuzzocrea et al 2007) and prevents vascular damage in experimental diabetic retinopathy (Pfister et al 2011).…”
Section: Positive Side Effectsmentioning
confidence: 99%
See 1 more Smart Citation
“…Most of the studies performed in the past were directed to demonstrate a particular abundance of carnosine-related dipeptides in the olfactory system, in the retina and, to a lesser extent, in the brain. The results of these studies will be briefly summarized here, since the earlier literature on this topic has been reviewed extensively (Crush, 1970;Margolis, 1980;Quinn et al, 1992).…”
Section: Carnosine-related Dipeptides In the Nervous Systemmentioning
confidence: 99%
“…[31,32] Since its discovery there have been many investigations into its biological function and it is now known that carnosine acts as an anti-oxidant, scavenger of free radicals and active oxygen species [30], as a biological buffer, a source for histidine, an immunostimulant and transition metal ion chelator, especially for Zn 2+ and Cu 2+ [33] and heavy metals. [34] The ability of carnosine to bind Zn 2+ helps modulate neuronal excitability by preventing the Zn 2+ inhibition of neurotransmitter receptors. [35] Carnosine is also effective in the prevention and partial reversal of cataracts [36] and in the treatment of Wilsons disease [37] and Alzheimers due to its metal chelating and free radical scavenging ability and also acting as a β-amyloid toxicity inhibitor.…”
Section: Introductionmentioning
confidence: 99%